The Future of Diversity in Clinical Trials: Real-World Evidence

This episode of tHEORetically Speaking features real-world evidence experts Alexandrina Balanean, MPH; Parisa Asgarisabet, PhD; and Danielle Gentile, PhD from Cardinal Health discussing the problems caused by lack of diverse representation in clinical trials.

The underrepresentation of disproportionately burdened groups limits information on therapeutic response, safety, and efficacy to a small subset of the population—which tends to be healthier, more well-educated, and financially advantaged. However, recent findings show that real-world evidence (RWE) may be able to help with this underrepresentation. Listen in to learn more about these findings and what it may mean for the future of RWE.

Reach out to us with your RWE needs by visiting cardinalhealth.com/RWE.

To watch the full interview, click here!